BrainsWay Future Growth
Future criteria checks 4/6
BrainsWay is forecast to grow earnings and revenue by 63.6% and 17% per annum respectively.
Key information
63.6%
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 17.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
BrainsWay: Cash Flow Doubts Weigh On The Stock
Nov 13BrainsWay: Operating Leverage Driving Upside
Aug 13BrainsWay: An Interesting Niche Concern
Jul 22BrainsWay: Profitable, Growing, And Cheap
Mar 07BrainsWay Q4 Earnings Preview
Feb 27BrainsWay gets significant private insurance coverage from Cigna for OCD treatment Utilizing Deep TMS
Sep 14BrainsWay adds 20% on FDA nod for depression therapy
Aug 29Brainsway GAAP EPS of -$0.07 in-line, revenue of $8.01M misses by $0.41M
Aug 10BrainsWay's Shares Look Attractive
Jul 12BrainsWay's Competitive Advantage Is Growing
Jan 21BrainsWay: Still Undervalued (Still)
Jun 02BrainsWay gets FDA clearance for Deep TMS protocol in major depressive disorder treatment
Apr 26Brainsway: Still Undervalued
Dec 24Brainsway +4% on Q3 beat, bottom-line up 66%
Nov 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 57 | 8 | N/A | 12 | 2 |
| 12/31/2025 | 47 | 4 | N/A | 8 | 4 |
| 12/31/2024 | 40 | 3 | N/A | 7 | 4 |
| 9/30/2024 | 39 | 2 | 6 | 9 | N/A |
| 6/30/2024 | 36 | 1 | 6 | 8 | N/A |
| 3/31/2024 | 34 | -2 | 5 | 8 | N/A |
| 12/31/2023 | 32 | -4 | -1 | 1 | N/A |
| 9/30/2023 | 29 | -8 | -3 | -3 | N/A |
| 6/30/2023 | 26 | -13 | -8 | -7 | N/A |
| 3/31/2023 | 26 | -14 | -10 | -10 | N/A |
| 12/31/2022 | 27 | -13 | -8 | -10 | N/A |
| 9/30/2022 | 30 | -11 | -5 | -4 | N/A |
| 6/30/2022 | 33 | -8 | -4 | -2 | N/A |
| 3/31/2022 | 32 | -7 | -4 | -2 | N/A |
| 12/31/2021 | 30 | -6 | -1 | 1 | N/A |
| 9/30/2021 | 28 | -6 | -2 | -1 | N/A |
| 6/30/2021 | 26 | -5 | -3 | -2 | N/A |
| 3/31/2021 | 24 | -5 | -1 | 1 | N/A |
| 12/31/2020 | 22 | -5 | -4 | -1 | N/A |
| 9/30/2020 | 21 | -7 | -7 | -4 | N/A |
| 6/30/2020 | 21 | -9 | -9 | -5 | N/A |
| 3/31/2020 | 22 | -12 | -13 | -9 | N/A |
| 12/31/2019 | 23 | -10 | -11 | -7 | N/A |
| 9/30/2019 | 22 | -10 | -11 | -7 | N/A |
| 6/30/2019 | 20 | -9 | -8 | -5 | N/A |
| 3/31/2019 | 18 | -7 | -6 | -4 | N/A |
| 12/31/2018 | 16 | -6 | -6 | -4 | N/A |
| 9/30/2018 | 15 | -7 | -5 | -3 | N/A |
| 6/30/2018 | 14 | -7 | N/A | -3 | N/A |
| 3/31/2018 | 13 | -6 | N/A | -2 | N/A |
| 12/31/2017 | 11 | -7 | N/A | -3 | N/A |
| 9/30/2017 | 10 | -6 | N/A | -4 | N/A |
| 6/30/2017 | 11 | -5 | N/A | -4 | N/A |
| 3/31/2017 | 11 | -3 | N/A | -4 | N/A |
| 12/31/2016 | 12 | -2 | N/A | -2 | N/A |
| 9/30/2016 | 11 | -3 | N/A | -2 | N/A |
| 6/30/2016 | 9 | -2 | N/A | -2 | N/A |
| 3/31/2016 | 8 | -4 | N/A | -3 | N/A |
| 12/31/2015 | 7 | -4 | N/A | -5 | N/A |
| 9/30/2015 | 6 | -5 | N/A | -5 | N/A |
| 6/30/2015 | 5 | -5 | N/A | -6 | N/A |
| 3/31/2015 | 4 | -5 | N/A | -5 | N/A |
| 12/31/2014 | 3 | -7 | N/A | -4 | N/A |
| 9/30/2014 | 3 | -5 | N/A | -4 | N/A |
| 6/30/2014 | 2 | -5 | N/A | -2 | N/A |
| 3/31/2014 | 2 | -5 | N/A | -3 | N/A |
| 12/31/2013 | 1 | -7 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BWAY's forecast earnings growth (63.6% per year) is above the savings rate (2.6%).
Earnings vs Market: BWAY's earnings (63.6% per year) are forecast to grow faster than the US market (15.4% per year).
High Growth Earnings: BWAY's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: BWAY's revenue (17% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: BWAY's revenue (17% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BWAY's Return on Equity is forecast to be high in 3 years time